This inventor holds 1 USPTO granted patent. Top assignee: Abbott Products Gmbh. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Klaus-Guenter Gerling: Innovator in Conjugated Equine Estrogens
Introduction
Klaus-Guenter Gerling is a notable inventor based in Winsen/Aller, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the extraction of natural compounds. His innovative methods have the potential to enhance the quality and efficacy of hormone therapies.
Latest Patents
Gerling holds a patent for a method titled "Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds." This patent describes a process for extracting a natural mixture of conjugated equine estrogens through liquid-liquid extraction. The method specifically aims to deplete the mixture of non-conjugated lipophilic compounds, which include various flavonoids, isoflavonoids, norisoprenoids, and steroids. This innovation is crucial for improving the purity and effectiveness of hormone replacement therapies.
Career Highlights
Klaus-Guenter Gerling is associated with Abbott Products GmbH, a company known for its commitment to advancing healthcare through innovative solutions. His work at Abbott has allowed him to focus on developing methods that enhance the extraction and application of natural compounds in medical treatments. His expertise in this area has positioned him as a valuable asset to the company and the pharmaceutical industry.
Collaborations
Gerling has collaborated with notable colleagues such as Ivan Ban and Hans-Joerg Mueller. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the development of effective pharmaceutical solutions.
Conclusion
Klaus-Guenter Gerling's contributions to the field of pharmaceuticals, particularly through his patented methods for extracting conjugated equine estrogens, highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for advancements in hormone therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile